Dietary whey protein protects against Crohn’s disease by orchestrating cross-kingdom interaction between the gut phageome and bacteriome.

What To Know

This article reports a multiomics study linking dietary whey protein (WP) consumption with changes in the gut phageome and bacteriome and a lower Crohn’s disease (CD) risk.

The researchers performed human dietary screening (n=140), in vitro phage–bacteria experiments, and two mouse models; they identify a WP-associated phage (AkkZT003P) and a probiotic-like bacterium implicated in reducing intestinal inflammation after WP exposure.

The article emphasizes a cross-kingdom mechanism: WP alters the phageome, the phage lyses a mucin-foraging bacterium, and that allows a symbiotic bacterium to expand and counteract inflammation.

The authors suggest WP, the keystone phage, and the probiotic could have future roles in CD management, but the piece reports early-stage translational research rather than clinical recommendations.

If you want the original study details, the Physicians Weekly summary cites BMJ Group publication and references PubMed; read the full paper for methods, statistics, and limitations before considering any diet changes.